Terms and Conditions of Use for https://pharmawatch.ameri-pharma.com

1. Terms

By accessing https://pharmawatch.ameri-pharma.com, you are agreeing to be bound by these Terms and Conditions of Use, all applicable laws and regulations, and agree that you are responsible for compliance with any applicable local, state, and federal regulations associated with the services of this website. If you do not agree with any of these terms or conditions of use, or are accessing the webpage with the intent of violating these terms, you are prohibited from using or accessing this website. The materials contained in this website are protected by all applicable copyright and trademark law.

2. User License

(a) Permission is granted to use the software available on https://pharmawatch.ameri-pharma.com for commercial non-transitory viewing only for as long as the account holder accessing the site remains in good standing with American Pharma Technologies Inc. This is the grant of a license, not a transfer of title, and under this license you may not:

  • (i) Modify the software;

  • (ii) Use the software for any public display (non-commercial);

  • (iii) Attempt to decompile, reverse engineer, or alter any software contained on https://pharmawatch.ameri-pharma.com or any other American Pharma Technologies Inc. website.

  • (iv) Remove any copyright or other proprietary notations from the materials; or

  • (v) Transfer the software to another person or 'mirror' the materials on any other server or system.

  • (vi) Access or attempt to access information or data that is not explicitly linked to your account.

(b) American Pharma Technologies Inc. reserves the right to terminate your license at any time in the event of a violation of these terms and conditions. If your license is terminated for this reason, you will not be entitled to a refund of any unused portion of your licensing fee.

(c) Ownership and terms of use of all customer data and information held by American Pharma Technologies Inc. are governed by the American Pharma Technologies Inc. Master Services Agreement, Paragraph G.

(c) Ownership and terms of use of all customer data and information held by American Pharma Technologies Inc. are governed by the American Pharma Master Services Agreement, Paragraph G.

3. Disclaimer

(a) The materials shown or accessible are provided with and adhere to regulatory guidelines for the accuracy and reliability of data. The data displayed in the software and/or application conforms to accuracy and reliability standards established by the following agencies and guidelines:

  • FDA cGMP Guidelines for Electronic Source Data

  • 21 CFR Part 11 Subpart C - Electronic Signatures

  • 21 CFR Part 11 Signature / Record linking

  • 21 CFR Part 11 Controls for open systems

  • National Institute of Standards and Technology Certification (where applicable to the means of data collection)

  • Specific reports for other agencies such as the user check-in report required by the CDC VFC program.

(b) Although the PharmaWatch system complies with 21 CFR Part 11 requirements where applicable, ultimate responsibility for 21 CFR Part 11 rests with persons responsible for electronic record content, just as the responsibility for compliance with paper records requirements generally lies with those responsible for the record's content.

4. Limitations and Exclusions

In no event shall American Pharma Technologies Inc. or its suppliers be liable for any damages including and without limitation to, damages for loss of data, loss of profit, and business interruption arising out of the use or inability to use the materials available via the software and/or application, even if an American Pharma Technologies Inc. authorized representative has been notified orally, in writing, or via email of the possibility of such damage. Because some regulatory jurisdictions do not allow limitations on implied limitations of liability for consequential or incidental damages, these limitations may not apply to you.

5. Revisions and Errors

The materials appearing or accessed via any software or application supplied by or represented by American Pharma Technologies may include technical, typographical, or photographic errors. American Pharma Technologies Inc. does not warrant that any of the materials available via the software and/or application are without these errors, complete, or current. American Pharma Technologies Inc. may make changes to the materials in its purview at any time and without notice. American Pharma Technologies Inc. will however report these changes at the request of a client or regulating agency (e.g. client audit). American Pharma Technologies Inc. does not make any commitment to update materials contained on- or accessed by the software and/or application, however; the software and/or application will be regularly updated to conform to the following regulatory standards and guidelines:

  • FDA cGMP Guidelines for Electronic Source Data

  • 21 CFR Part 11 Subpart C - Electronic Signatures

  • 21 CFR Part 11 Signature / Record linking

  • 21 CFR Part 11 Controls for open systems

  • National Institute of Standards and Technology

6. Links

American Pharma Technologies Inc. has reviewed all of the sites linked to https://pharmawatch.ameri-pharma.com, however, American Pharma Technologies Inc. may not be responsible for the contents of any such linked site. The inclusion of any link does not imply endorsement by American Pharma Technologies Inc. of the site or content thereof.

7. Governing Law(s)

Any claim relating to the software and/or applications supplied by or represented by American Pharma Technologies Inc. shall be governed by the laws of the State of Idaho without regard to its conflict of law provisions.

8. Website Terms of Use Modifications

American Pharma Technologies Inc. may make revisions to these terms of use for its Website at any time. Notice will be provided in the form of a change in revision date at the bottom of these terms. By using this Website you are agreeing to be bound by the then current version of these Terms and Conditions of Use.

If we decide to change our terms of use, we will post those changes at this location, and update the Terms of Use modification date below.

This policy was last modified on 1/31/2016.

9. Contact Information

If there are any questions regarding these terms and conditions of use, you may contact us using the information below.

American Pharma Technologies Inc.
https://www.ameri-pharma.com
280 N. 8th St. Suite 205
Boise, Idaho 83702
United States
info@ameri-pharma.com
1-888-234-5157